No­vo Hold­ings to help young Dan­ish com­pa­ny with ef­forts to pro­vide scale to start-ups

A Dan­ish bio in­dus­tri­al scale-up com­pa­ny has land­ed an $86 mil­lion in­vest­ment from No­vo Hold­ings, and it’s hop­ing to build on a tech­nol­o­gy base from Novozymes. And with that in­vest­ment will come a new man­u­fac­tur­ing site.

21st.BIO was found­ed in 2020, and is fo­cused on sup­port­ing the up­scal­ing of com­pa­nies across the world, with the in­ten­tion of help­ing those com­pa­nies meet mar­ket de­mand. Its fo­cus are pep­tides and pro­teins, and it wants to pro­vide star­tups ac­cess to fa­cil­i­ties to de­vel­op a mol­e­cule pro­duc­tion process that can de­liv­er a high-qual­i­ty prod­uct in the most cost-ef­fec­tive way.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER